Application 203733
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LAMOTRIGINE | LAMOTRIGINE | TABLET, EXTENDED RELEASE;ORAL | 250MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0228-1638 | Lamotrigine | Lamotrigine | Actavis Pharma, Inc. | ANDA | Current |
| 0228-1638 | Lamotrigine | Lamotrigine | Actavis Pharma, Inc. | ANDA | Current |
| 0228-1638 | Lamotrigine | Lamotrigine | Actavis Pharma, Inc. | ANDA | Current |
| 0228-1638 | Lamotrigine | Lamotrigine | Actavis Pharma, Inc. | ANDA | Current |
| 0228-1638 | Lamotrigine | Lamotrigine | Actavis Pharma, Inc. | ANDA | Current |
| 0228-1638 | Lamotrigine | Lamotrigine | Actavis Pharma, Inc. | ANDA | Current |